2hjl: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2hjl.gif|left|200px]]<br /> | [[Image:2hjl.gif|left|200px]]<br /><applet load="2hjl" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2hjl" size=" | |||
caption="2hjl, resolution 1.500Å" /> | caption="2hjl, resolution 1.500Å" /> | ||
'''Crystal Structure of HLA-B5703 and HIV-1 peptide'''<br /> | '''Crystal Structure of HLA-B5703 and HIV-1 peptide'''<br /> | ||
==Overview== | ==Overview== | ||
HLA-B*57 is associated with slower disease progression to AIDS, and CD8+ T | HLA-B*57 is associated with slower disease progression to AIDS, and CD8+ T cell responses to B*57-restricted epitopes are thought to contribute to this protective effect. In this study, we evaluate the B*57-restricted p24 KAFSPEVIPMF (KF11) immune response which is immunodominant during chronic infection. Previously, we observed that the KF11 clade variants KGFNPEVIPMF [A2G,S4N] and KAFNPEIIMPF [S4N,V7I], sharing a position 4 mutation, are differentially recognized by KF11-specific T cells. By combining structural and cellular studies, we now demonstrate that the KF11 and [A2G,S4N] epitopes induce distinct functional responses in [A2G,S4N] and KF11-specific T cells, respectively, despite minimal structural differences between the individual B*57-peptide complexes. Recently, we also elucidated the highly distinct structure of KF11 in complex with B*5703, and have now characterized the CD8+ T cell repertoire recognizing this epitope. We now report striking features of TCR conservation both in terms of TCR Valpha and Vbeta chain usage, and throughout the hypervariable region. Collectively, our findings highlight unusual features of the B*5701/B*5703-KF11-specific immune responses which could influence disease progression and that might be important to consider when designing future vaccine regimens. | ||
==Disease== | ==Disease== | ||
Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
2HJL is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http:// | 2HJL is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HJL OCA]. | ||
==Reference== | ==Reference== | ||
Line 18: | Line 17: | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
[[Category: Beattie, T.]] | [[Category: Beattie, T.]] | ||
[[Category: Bwayo, J | [[Category: Bwayo, J J.]] | ||
[[Category: Gillespie, G | [[Category: Gillespie, G M.A.]] | ||
[[Category: Plummer, F | [[Category: Plummer, F A.]] | ||
[[Category: Rengasamy, J.]] | [[Category: Rengasamy, J.]] | ||
[[Category: Stewart-Jones, G.]] | [[Category: Stewart-Jones, G.]] | ||
Line 27: | Line 26: | ||
[[Category: hla]] | [[Category: hla]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:42:33 2008'' |